Jula Inrig
EVP, Head of R&D & CMO at Travere Therapeutics · 15 reported transactions in 1 company · latest trade Sep 15, 2026
Their trades
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days. | ||
Sold | Feb 4, 2026 | Feb 4, 2026 close $31.68 → Oct 30, 2026 close $50.39. S&P 500 +10.1% over the same days. | ||
Sold | Feb 4, 2026 | Feb 4, 2026 close $31.68 → Oct 30, 2026 close $50.39. S&P 500 +10.1% over the same days. | ||
Sold | Feb 3, 2026 | Feb 3, 2026 close $32.84 → Oct 30, 2026 close $50.39. S&P 500 +9.6% over the same days. |
$26.1K
Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days.
$101.9K
Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days.
$1.08M
Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days.
$1.57M
Sep 15, 2026 close $62.51 → Oct 30, 2026 close $50.39. S&P 500 −0.2% over the same days.
$7.6K
Feb 4, 2026 close $31.68 → Oct 30, 2026 close $50.39. S&P 500 +10.1% over the same days.
$49.7K
Feb 4, 2026 close $31.68 → Oct 30, 2026 close $50.39. S&P 500 +10.1% over the same days.
$223.4K
Feb 3, 2026 close $32.84 → Oct 30, 2026 close $50.39. S&P 500 +9.6% over the same days.